{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-232585","form_type":"8-K","ticker":"SGHT","cik":"0001531177","company_name":"Sight Sciences, Inc.","filed_at":"2023-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.220473+00:00","generated_at":"2026-06-10T21:40:55.711263+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sight Sciences cuts FY2023 guidance to $80-82M, cites LCD uncertainty; appoints Matt Link CCO","bullets":["Q3 guidance $19-20M; FY guidance cut to $80-82M from $89-94M (12-15% YoY growth).","Proposed LCDs by 5 of 7 MACs could classify non-implantable MIGS as investigational, affecting orders.","Matt Link appointed CCO; former NuVasive President who scaled revenue from <$100M to >$1B.","Link receives $410K base salary, 50% bonus target, $660K options, and $1.54M RSUs."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-232585","json":"https://secwatch.observer/filing/0001193125-23-232585.json","markdown":"https://secwatch.observer/filing/0001193125-23-232585.md","text":"https://secwatch.observer/filing/0001193125-23-232585.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1531177/000119312523232585/0001193125-23-232585-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1531177/000119312523232585/d507422d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T21:40:55.711263+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2a52084b2c","claim":"Matthew Link was appointed as Chief Commercial Officer at Sight Sciences, Inc..","evidence_excerpt":"Effective September 11, 2023, Matthew Link was appointed by the board of directors (the “Board”) of Sight Sciences, Inc. (the “Company”) to serve as the Company’s Chief Commercial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531177/000119312523232585/0001193125-23-232585-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}